Skip to Main Content

Paper Details

Cardiovascular outcomes among patients with castration-resistant prostate cancer: A comparative safety study using US administrative claims data.
Prostate
3
2023
AAP, AMI, CRPC, Cardiovascular conditions, ENZ, HHF, abiraterone acetate, acute myocardial infarction, advanced prostate cancer, androgen, castration-resistant prostate cancer, heart failure, ischemic stroke, men, metastatic castrate resistant prostate cancer, myocardial infarction, patients, predniso(lo)ne, prostate cancer

Datasets